FDA
-
-
-
-
-
-
-
NeOnc gets UAE approval for NEO100 brain cancer drug trials
-
-
-
-
-
-
-
Wall Street Chases the Next Big Breakout
-
-
-
-
-
-
-
NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts
-
-
-
-
-
-
-
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity
-
-
-
-
-
-
-
NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update
-
-
-
-
-
-
-
NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on “Health Uncensored with Dr. Drew” on the Lifetime Network on September 25, premiering nationwide a
-
-
-
-
-
-
-
NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia
-
326,426 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

